Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TAF4 anticorps (AA 454-565)

Cet anticorps Souris Monoclonal détecte spécifiquement TAF4 dans WB et IF. Il présente une réactivité avec des échantillons de Humain et Souris. Il a été cité dans 4+ publications.
N° du produit ABIN968728
164,17 €
Plus frais de livraison 40,00 € et TVA
50 μg
Destination: France
Envoi sous 12 à 15 jours ouvrables

Aperçu rapide pour TAF4 anticorps (AA 454-565) (ABIN968728)

Antigène

Voir toutes TAF4 Anticorps
TAF4 (TAF4 RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor, 135kDa (TAF4))

Reactivité

  • 25
  • 17
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain, Souris

Hôte

  • 23
  • 3
Souris

Clonalité

  • 24
  • 2
Monoclonal

Conjugué

  • 19
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp TAF4 est non-conjugé

Application

  • 17
  • 9
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF)

Clone

22-TAF[II]135
  • Épitope

    • 6
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 454-565

     Réactivité croisée

    Souris

    Attributs du produit

    1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
    2. Please refer to us for technical protocols.
    3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
    4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.

    Purification

    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

    Immunogène

    Human TAF[II]135 aa. 454-565

    Isotype

    IgG1
  • Commentaires

    Related Products: ABIN968537, ABIN967389

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    250 μg/mL

    Buffer

    Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store undiluted at -20°C.
  • Freiman, Albright, Chu, Zheng, Liang, Sha, Tjian: "Redundant role of tissue-selective TAF(II)105 in B lymphocytes." dans: Molecular and cellular biology, Vol. 22, Issue 18, pp. 6564-72, (2002) (PubMed).

    Shimohata, Nakajima, Yamada, Uchida, Onodera, Naruse, Kimura, Koide, Nozaki, Sano, Ishiguro, Sakoe, Ooshima, Sato, Ikeuchi, Oyake, Sato, Aoyagi, Hozumi, Nagatsu, Takiyama, Nishizawa, Goto, Kanazawa et al.: "Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. ..." dans: Nature genetics, Vol. 26, Issue 1, pp. 29-36, (2000) (PubMed).

    Saluja, Vassallo, Tanese: "Distinct subdomains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators." dans: Molecular and cellular biology, Vol. 18, Issue 10, pp. 5734-43, (1998) (PubMed).

    Mengus, May, Carré, Chambon, Davidson: "Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells." dans: Genes & development, Vol. 11, Issue 11, pp. 1381-95, (1997) (PubMed).

  • Antigène

    TAF4 (TAF4 RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor, 135kDa (TAF4))

    Autre désignation

    TAF II135

    Sujet

    Tightly associated factors (TAFs) play an essential role in transcriptional activation through their interaction with a variety of activators. TAF[II]135 (a.k.a. TAF[II]130) is a human homologue of Drosophila TAF[II]110, the first TAF shown to have coactivator activity. TAF[II]135 contains multiple glutamine-rich regions, as well as a coactivator domain (CAD). The glutamine-rich regions of TAF[II]135 facilitate interaction with Sp1 and CREB, which leads to enhancement of both Sp1- and CREB-mediated transcription. In addition, TAF[II]135 can potentiate transcriptional stimulation by AF-2 of the retinoic acid, thyroid hormone, and vitamine D3 receptors. However, TAF[II]135 does not interact with the AF-2s of the estrogen and retinoid X receptors. Interestingly, TAF[II]135 enhancement of CREB transcriptional activity may be disrupted by expanded polyglutamine (CAG) repeats found in at least eight different neurodegenerative disorders. Thus, TAF[II]135 may have important coactivator activities in many different transcription-regulating cell signaling pathways, and interference of TAF[II]135 activity by CAG repeats may be a common mechanism of specific types of neuropathologies.

    Poids moléculaire

    135 kDa
Vous êtes ici:
Chat with us!